In experiments with dendritic cells transfected with anti-CTLA-4 antibody mRNA, the activity of this immune modulator was associated with the enhancement of antigen-specific cytotoxic T lymphocytes (CTL) responses against breast cancer cells, including MCF-7, MDA-MB-231, and T4D7 cell lines [34]. Here, CTLA4 is linked to breast carcinoma.